Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity (Q43713676)

26 November 2017

Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity (English)

1 reference

26 November 2017

8

Hiroyuki Okamoto

1 reference

26 November 2017

Ikuko Ueda-Hayakawa

1

1 reference

26 November 2017

Hirotsugu Tanimura

2

1 reference

26 November 2017

Manabu Osawa

3

1 reference

26 November 2017

Hiroshi Iwasaka

4

1 reference

26 November 2017

Shuichi Ohe

5

1 reference

26 November 2017

Fumikazu Yamazaki

6

1 reference

26 November 2017

Kana Mizuno

7

1 reference

26 November 2017

language of work or name

1 reference

17 May 2013

1 reference

26 November 2017

1 reference

26 November 2017

52

1 reference

26 November 2017

9

1 reference

26 November 2017

1658-1666

1 reference

New pathogenetic insights into the sarcoid granuloma

26 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Altered immunologic activity in sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

BAFF AND APRIL: a tutorial on B cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Elevation of serum angiotension-converting-enzyme (ACE) level in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Usefulness of Serum Lysozyme Measurement in Diagnosis and Evaluation of Sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Heightened ability of monocytes from sarcoidosis patients to form multi-nucleated giant cells in vitro by supernatants of concanavalin A-stimulated mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

BAFF mediates survival of peripheral immature B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKET186

10.1093/RHEUMATOLOGY/KET186

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference